GB0015761D0 - Polypeptide - Google Patents
PolypeptideInfo
- Publication number
- GB0015761D0 GB0015761D0 GB0015761A GB0015761A GB0015761D0 GB 0015761 D0 GB0015761 D0 GB 0015761D0 GB 0015761 A GB0015761 A GB 0015761A GB 0015761 A GB0015761 A GB 0015761A GB 0015761 D0 GB0015761 D0 GB 0015761D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0015761A GB0015761D0 (en) | 2000-06-27 | 2000-06-27 | Polypeptide |
AU2001274344A AU2001274344A1 (en) | 2000-06-27 | 2001-06-27 | Tissue inhibitors of matrix metalloproteinases |
PCT/GB2001/002861 WO2002006480A2 (en) | 2000-06-27 | 2001-06-27 | Tissue inhibitors of matrix metalloproteinases |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0015761A GB0015761D0 (en) | 2000-06-27 | 2000-06-27 | Polypeptide |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0015761D0 true GB0015761D0 (en) | 2000-08-16 |
Family
ID=9894527
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0015761A Ceased GB0015761D0 (en) | 2000-06-27 | 2000-06-27 | Polypeptide |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2001274344A1 (en) |
GB (1) | GB0015761D0 (en) |
WO (1) | WO2002006480A2 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10138550A1 (en) * | 2001-08-06 | 2003-02-20 | Wolfgang E Berdel | Use of tissue inhibitor of metalloprotease-1 and encoding nucleic acid, as immunosuppressant, e.g. for treating multiple sclerosis, rheumatoid arthritis, chronic hepatitis C and asthma |
WO2017120461A1 (en) | 2016-01-08 | 2017-07-13 | The Board Of Trustees Of The Leland Stanford Junior University | Ccr3 modulation in the treatment of aging-associated impairments, and compositions for practicing the same |
US20160208011A1 (en) | 2010-01-28 | 2016-07-21 | The Board Of Trustees Of The Leland Stanford Junior University | Ccr3 modulation in the treatment of aging-associated impairments, and compositions for practicing the same |
US10487148B2 (en) | 2010-01-28 | 2019-11-26 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for treating aging-associated impairments |
US9161968B2 (en) | 2011-04-08 | 2015-10-20 | The Board Of Trustees Of The Leland Stanford Junior University | Methods of neuroprotection involving macrophage colony stimulating factor receptor agonists |
MX2016007492A (en) | 2013-12-09 | 2017-03-06 | Univ Leland Stanford Junior | Methods and compositions for treating aging-associated conditions. |
US10905779B2 (en) | 2013-12-09 | 2021-02-02 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for screening human blood products comprising plasma using immunocompromised rodent models |
JP6921006B2 (en) | 2015-06-15 | 2021-08-18 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | Methods and compositions for treating aging-related symptoms |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE219776T1 (en) * | 1989-03-21 | 2002-07-15 | Us Secretary United States Dep | MATRIC METALLOPROTEINASE INHIBITOR PEPTIDES |
AU3429993A (en) * | 1992-01-10 | 1993-08-03 | Georgetown University | A method of administering genetically engineered endothelial cells to sites of angiogenesis for effecting genetic therapy |
US6562596B1 (en) * | 1993-10-06 | 2003-05-13 | Amgen Inc. | Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods |
JPH1017492A (en) * | 1996-07-02 | 1998-01-20 | Fuji Yakuhin Kogyo Kk | Tumor cell proliferation suppressant |
DE19850986A1 (en) * | 1998-11-05 | 2000-05-25 | Aventis Pharma Gmbh | The genetic engineering of cells and their use for the prophylaxis and therapy of diseases |
-
2000
- 2000-06-27 GB GB0015761A patent/GB0015761D0/en not_active Ceased
-
2001
- 2001-06-27 AU AU2001274344A patent/AU2001274344A1/en not_active Abandoned
- 2001-06-27 WO PCT/GB2001/002861 patent/WO2002006480A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2002006480A3 (en) | 2004-02-26 |
AU2001274344A1 (en) | 2002-01-30 |
WO2002006480A2 (en) | 2002-01-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0014870D0 (en) | Peptides | |
AU8441801A (en) | Novel polypeptide | |
GB0029777D0 (en) | Peptides | |
GB0015761D0 (en) | Polypeptide | |
GB0127017D0 (en) | New polypeptide | |
GB0001825D0 (en) | Peptides | |
GB0120704D0 (en) | Polypeptide | |
GB0124559D0 (en) | New polypeptide | |
GB0127028D0 (en) | New polypeptide | |
EP1354947A4 (en) | Novel polypeptide | |
GB0013239D0 (en) | Polypeptide | |
GB0007263D0 (en) | Peptides | |
EP1179592A4 (en) | Proteins nectin-3 | |
GB0012199D0 (en) | New polypeptide | |
GB0030293D0 (en) | Polypeptide | |
GB0021524D0 (en) | Polypeptide | |
GB0019861D0 (en) | Polypeptide | |
GB0010170D0 (en) | Polypeptide | |
GB0027166D0 (en) | Polypeptide | |
GB0023444D0 (en) | Polypeptide | |
GB0018307D0 (en) | Polypeptides | |
GB0019859D0 (en) | New polypeptide | |
GB0024445D0 (en) | New polypeptide | |
GB0009060D0 (en) | New polypeptide | |
GB0030501D0 (en) | New polypeptide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |